216 related articles for article (PubMed ID: 36499477)
1. Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer's Disease Neurodegeneration.
Bartra C; Irisarri A; Villoslada A; Corpas R; Aguirre S; García-Lara E; Suñol C; Pallàs M; Griñán-Ferré C; Sanfeliu C
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499477
[TBL] [Abstract][Full Text] [Related]
2. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
[TBL] [Abstract][Full Text] [Related]
3. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
4. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
[TBL] [Abstract][Full Text] [Related]
5. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease.
Ghosh A; Comerota MM; Wan D; Chen F; Propson NE; Hwang SH; Hammock BD; Zheng H
Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298560
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes.
Pardeshi R; Bolshette N; Gadhave K; Arfeen M; Ahmed S; Jamwal R; Hammock BD; Lahkar M; Goswami SK
Front Pharmacol; 2019; 10():288. PubMed ID: 31068802
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
8. A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer's Disease Mice Models.
Jarne-Ferrer J; Griñán-Ferré C; Bellver-Sanchis A; Vázquez S; Muñoz-Torrero D; Pallàs M
Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893732
[TBL] [Abstract][Full Text] [Related]
9. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
10. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms.
Sarroca S; Gatius A; Rodríguez-Farré E; Vilchez D; Pallàs M; Griñán-Ferré C; Sanfeliu C; Corpas R
J Nutr Biochem; 2021 Mar; 89():108569. PubMed ID: 33321185
[TBL] [Abstract][Full Text] [Related]
12. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice.
Griñán-Ferré C; Sarroca S; Ivanova A; Puigoriol-Illamola D; Aguado F; Camins A; Sanfeliu C; Pallàs M
Aging (Albany NY); 2016 Apr; 8(4):664-84. PubMed ID: 27013617
[TBL] [Abstract][Full Text] [Related]
14. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
Faridar A; Vasquez M; Thome AD; Yin Z; Xuan H; Wang JH; Wen S; Li X; Thonhoff JR; Zhao W; Zhao H; Beers DR; Wong STC; Masdeu JC; Appel SH
Acta Neuropathol Commun; 2022 Sep; 10(1):144. PubMed ID: 36180898
[TBL] [Abstract][Full Text] [Related]
16. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
[TBL] [Abstract][Full Text] [Related]
17. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions.
Tible M; Mouton Liger F; Schmitt J; Giralt A; Farid K; Thomasseau S; Gourmaud S; Paquet C; Rondi Reig L; Meurs E; Girault JA; Hugon J
Aging Cell; 2019 Jun; 18(3):e12887. PubMed ID: 30821420
[TBL] [Abstract][Full Text] [Related]
18. Environmental Enrichment Improves Cognitive Deficits, AD Hallmarks and Epigenetic Alterations Presented in 5xFAD Mouse Model.
Griñán-Ferré C; Izquierdo V; Otero E; Puigoriol-Illamola D; Corpas R; Sanfeliu C; Ortuño-Sahagún D; Pallàs M
Front Cell Neurosci; 2018; 12():224. PubMed ID: 30158856
[TBL] [Abstract][Full Text] [Related]
19. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice.
Jiang Y; Li K; Li X; Xu L; Yang Z
Chem Biol Interact; 2021 May; 341():109452. PubMed ID: 33785315
[TBL] [Abstract][Full Text] [Related]
20. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
